Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 13, 2026 07:28 ET | Source: Research and Markets

Comprehensive Nerve Repair Biomaterials Market Report Published, Profiles Medtronic, Stryker, Boston Scientific, and 20 Other Key Players

Dublin, July 13, 2026 (GLOBE NEWSWIRE) -- The "Nerve Repair Biomaterials Market Report 2026" has been added to ResearchAndMarkets.com's offering. The nerve repair biomaterials market is...
July 02, 2025 09:22 ET | Source: SNS Insider pvt ltd

Nerve Repair and Regeneration Market to Reach USD 25.67 Billion by 2032, Driven by Breakthroughs in Neurostimulation and Biomaterials – SNS Insider

Austin, July 02, 2025 (GLOBE NEWSWIRE) -- Nerve Repair and Regeneration Market Size & Growth Analysis: According to SNS Insider, the global Nerve Repair and Regeneration Market was valued at...
July 23, 2024 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Report Second Quarter 2024 Financial Results and Host Conference Call on August 8, 2024

ALACHUA and TAMPA, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...
May 16, 2024 07:00 ET | Source: Axogen, Inc.

Axogen Inc. Initiates Rolling Submission of Biologics License Application to U.S. Food and Drug Administration (FDA) for Avance Nerve Graft®

ALACHUA, Fla. and TAMPA, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
May 02, 2024 07:00 ET | Source: Axogen, Inc.

Axogen, Inc Reports First Quarter 2024 Financial Results

ALACHUA, Fla. and TAMPA, Fla., May 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
February 02, 2024 16:15 ET | Source: Axogen, Inc.

Company Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

ALACHUA, Fla. and TAMPA, Fla., Feb. 02, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
January 18, 2024 17:00 ET | Source: Axogen, Inc.

Axogen, Inc. Announces Positive Topline Results from REPOSE, a Prospective, Randomized Clinical Trial of Axoguard Nerve Cap

REPOSE® met its primary endpoint of non-inferiority between the pain visual analog scale outcomes for neurectomy with Axoguard Nerve Cap® vs. standard-of-care neurectomy at Month 12. Axoguard Nerve...
January 04, 2024 16:35 ET | Source: Axogen, Inc.

Axogen Announces Promotions on Research and Development Team

ALACHUA, Fla. and TAMPA, Fla., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve...
December 06, 2023 07:00 ET | Source: Axogen, Inc.

Axogen Announces Transition of Finance Team Leadership

ALACHUA, Fla. and TAMPA, Fla., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries,...
November 20, 2023 07:00 ET | Source: Axogen, Inc.

Axogen, Inc. to Participate at the Piper Sandler 35th Annual Healthcare Conference

ALACHUA and TAMPA, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today...